Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.

Saved in:
Bibliographic Details
Title: Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.
Authors: Hellmann MD; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address: hellmanm@mskcc.org., Sturm I; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany., Trnkova ZJ; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany., Lettieri J; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Whippany, NJ., Diefenbach K; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany., Rizvi NA; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY., Gettinger SN; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, New Haven, CT.
Source: Clinical lung cancer [Clin Lung Cancer] 2015 Nov; Vol. 16 (6), pp. 514-22. Date of Electronic Publication: 2015 Apr 20.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26003007
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hellmann+MD%22">Hellmann MD</searchLink>; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address: hellmanm@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Sturm+I%22">Sturm I</searchLink>; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Trnkova+ZJ%22">Trnkova ZJ</searchLink>; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lettieri+J%22">Lettieri J</searchLink>; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Whippany, NJ.<br /><searchLink fieldCode="AU" term="%22Diefenbach+K%22">Diefenbach K</searchLink>; Department of Clinical Pharmacology Oncology, Bayer HealthCare, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Rizvi+NA%22">Rizvi NA</searchLink>; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY.<br /><searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Department of Medicine, Section of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, New Haven, CT.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2015 Nov; Vol. 16 (6), pp. 514-22. <i>Date of Electronic Publication: </i>2015 Apr 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26003007
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2015.04.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 514
    Titles:
      – TitleFull: Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hellmann MD
      – PersonEntity:
          Name:
            NameFull: Sturm I
      – PersonEntity:
          Name:
            NameFull: Trnkova ZJ
      – PersonEntity:
          Name:
            NameFull: Lettieri J
      – PersonEntity:
          Name:
            NameFull: Diefenbach K
      – PersonEntity:
          Name:
            NameFull: Rizvi NA
      – PersonEntity:
          Name:
            NameFull: Gettinger SN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2015 Nov
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1